Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Revista Medica De Chile
|
November 9, 2021
[Pharmacokinetic interactions of fruit juices and herbal preparations]
Matías Cortés, Rodrigo Díaz, Samuel Verdugo, et al.
Drug Metabolism and Personalized Therapy
|
January 26, 2020
Dosage of phenytoin in neurocritical patients using Bayesian algorithms: a pilot study
Daniel Muñoz-Pichuante, Lorenzo Villa Zapata, Salvador Cabrera, et al.
AIDS Patient Care and Stds
|
October 30, 2009
Hyperhidrosis in association with efavirenz
Aurelio Fuertes, Aurelio Fuertes Martín, Salvador Cabrera, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2011
Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients
Almudena Sánchez, Salvador Cabrera, Dolores Santos, et al.
Personalized Medicine
|
June 28, 2024
Usefulness of vancomycin treatment individualization via Bayesian algorithms: a 5-year study in critical patients
Salvador Cabrera Figueroa, Diego Salazar Pincheira, Claudio Bustos Navarrete, et al.
Revista Medica Del Instituto Mexicano Del Seguro Social
|
May 6, 2026
[Cost-effectiveness of the Lose Weight, Gain Life program]
Ronald González-Espejel, Rodolfo Rivas-Ruiz, Sergio Carlos Fernández-Martínez, et al.
Pharmacogenomics
|
July 18, 2013
Impact of pharmacogenetics on CNS side effects related to efavirenz
Almudena Sánchez Martín, Salvador Cabrera Figueroa, Raquel Cruz Guerrero, et al.
Clinical Drug Investigation
|
May 6, 2010
Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV
Salvador Cabrera Figueroa, Alicia Iglesias Gómez, Almudena Sánchez Martín, et al.
Drug Metabolism and Pharmacokinetics
|
September 27, 2016
Gene-gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients
Almudena Sánchez-Martín, Salvador Cabrera Figueroa, Raquel Cruz, et al.
Therapeutic Drug Monitoring
|
September 14, 2011
Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients
Elena López Aspiroz, Dolores Santos Buelga, Salvador Cabrera Figueroa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Revista Medica De Chile
|
November 9, 2021
[Pharmacokinetic interactions of fruit juices and herbal preparations]
Matías Cortés, Rodrigo Díaz, Samuel Verdugo, et al.
Drug Metabolism and Personalized Therapy
|
January 26, 2020
Dosage of phenytoin in neurocritical patients using Bayesian algorithms: a pilot study
Daniel Muñoz-Pichuante, Lorenzo Villa Zapata, Salvador Cabrera, et al.
AIDS Patient Care and Stds
|
October 30, 2009
Hyperhidrosis in association with efavirenz
Aurelio Fuertes, Aurelio Fuertes Martín, Salvador Cabrera, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2011
Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients
Almudena Sánchez, Salvador Cabrera, Dolores Santos, et al.
Personalized Medicine
|
June 28, 2024
Usefulness of vancomycin treatment individualization via Bayesian algorithms: a 5-year study in critical patients
Salvador Cabrera Figueroa, Diego Salazar Pincheira, Claudio Bustos Navarrete, et al.
Revista Medica Del Instituto Mexicano Del Seguro Social
|
May 6, 2026
[Cost-effectiveness of the Lose Weight, Gain Life program]
Ronald González-Espejel, Rodolfo Rivas-Ruiz, Sergio Carlos Fernández-Martínez, et al.
Pharmacogenomics
|
July 18, 2013
Impact of pharmacogenetics on CNS side effects related to efavirenz
Almudena Sánchez Martín, Salvador Cabrera Figueroa, Raquel Cruz Guerrero, et al.
Clinical Drug Investigation
|
May 6, 2010
Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV
Salvador Cabrera Figueroa, Alicia Iglesias Gómez, Almudena Sánchez Martín, et al.
Drug Metabolism and Pharmacokinetics
|
September 27, 2016
Gene-gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients
Almudena Sánchez-Martín, Salvador Cabrera Figueroa, Raquel Cruz, et al.
Therapeutic Drug Monitoring
|
September 14, 2011
Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients
Elena López Aspiroz, Dolores Santos Buelga, Salvador Cabrera Figueroa, et al.
Page
of 2